As a FDA-approved neurotoxin, Botulinum Toxin Type A (including Botox®, Xeomin®, and Dysport®) has become the gold standard in medical aesthetics since 2002. By temporarily blocking acetylcholine release, it safely reduces muscle activity in targeted areas—clinically proven to correct dynamic wrinkles (e.g., crow’s feet, forehead lines) with over 89% patient satisfaction rate (Journal of Cosmetic Dermatology, 2023)
⚠️ IMPORTANT: Botulinum Toxin is a prescription-only medication.
Eligible Buyers: Licensed clinics/hospitals with valid medical practice certificates.
Verification Required: Submit credentials during registration (e.g., medical license, business permit).
Legal Compliance: All products meet import regulations of destination countries.”
Achieving Safe & Effective Results
Mechanism: Botulinum Toxin Type A binds to SNAP-25 proteins, inhibiting acetylcholine release for 3-12 months depending on injection sites.
Dosage Guidelines:
Glabellar Lines: 20-30U (Botulax®)
Masseter Reduction: 25-50U/side (Nabota®)
Contraindications:
Avoid in patients with neuromuscular disorders (e.g., myasthenia gravis)
Pregnancy/Nursing: Risk Category C (FDA)
